These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31239044)

  • 1. Ligand-observed NMR techniques to probe RNA-small molecule interactions.
    Calabrese DR; Connelly CM; Schneekloth JS
    Methods Enzymol; 2019; 623():131-149. PubMed ID: 31239044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR characterization of RNA small molecule interactions.
    Thompson RD; Baisden JT; Zhang Q
    Methods; 2019 Sep; 167():66-77. PubMed ID: 31128236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Binding of Small Molecules to Intrinsically Disordered Proteins.
    Dobrev VS; Fred LM; Gerhart KP; Metallo SJ
    Methods Enzymol; 2018; 611():677-702. PubMed ID: 30471704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting RNA structures in diseases with small molecules.
    Shao Y; Zhang QC
    Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring weak ligand-protein interactions by long-lived NMR states: improved contrast in fragment-based drug screening.
    Buratto R; Mammoli D; Chiarparin E; Williams G; Bodenhausen G
    Angew Chem Int Ed Engl; 2014 Oct; 53(42):11376-80. PubMed ID: 25196717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
    Hanzawa H; Shimada T; Takahashi M; Takahashi H
    J Biomol NMR; 2020 Nov; 74(10-11):501-508. PubMed ID: 32306215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR in target driven drug discovery: why not?
    Keiffer S; Carneiro MG; Hollander J; Kobayashi M; Pogoryelev D; Ab E; Theisgen S; Müller G; Siegal G
    J Biomol NMR; 2020 Nov; 74(10-11):521-529. PubMed ID: 32901320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NMR screening in fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Yakugaku Zasshi; 2010 Mar; 130(3):325-33. PubMed ID: 20190517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery.
    Arntson KE; Pomerantz WC
    J Med Chem; 2016 Jun; 59(11):5158-71. PubMed ID: 26599421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery.
    Hu J; Eriksson PO; Kern G
    Magn Reson Chem; 2010 Dec; 48(12):909-11. PubMed ID: 21038321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Orientation Based Fragment Selection in STD NMR Screening.
    Cala O; Krimm I
    J Med Chem; 2015 Nov; 58(21):8739-42. PubMed ID: 26492576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles for targeting RNA with drug-like small molecules.
    Warner KD; Hajdin CE; Weeks KM
    Nat Rev Drug Discov; 2018 Aug; 17(8):547-558. PubMed ID: 29977051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of 2D Difference Intensity Analysis for Chemical Library Screening by Protein-Detected NMR Spectroscopy.
    Egner JM; Jensen DR; Olp MD; Kennedy NW; Volkman BF; Peterson FC; Smith BC; Hill RB
    Chembiochem; 2018 Mar; 19(5):448-458. PubMed ID: 29239081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.